{"nct_id":"NCT01342913","title":"A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))","status":"COMPLETED","status_verified_date":"2018-08","start_date":"2011-02-01","start_date_type":null,"primary_completion_date":"2011-10-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-10-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}